Skip to content
The market continues to reward companies with B2B contracts

The market continues to reward companies with B2B contracts

The biggest deals and news of the week, plus an interview with Embold Health president and founder Daniel Stein
9 min read

Everyone in the industry should be paying attention to the Talkspace acquisition because it’s emblematic of a lot of the deals that I suspect will happen in the next 12 months. It’s a relatively healthy outcome for the industry, so it might also inspire some IPOs for companies that are waiting in the wings. 

It shows a few things about what the market is rewarding: 

  1. B2B contracts are heavily favored as a mechanism to build to scale and acquire patients without spending enormous marketing costs.
  2. Strategics see value in digital health as a potential “front door”;
  3. There’s a finite pool of providers, so incumbents are willing to spend on tech-enabled services to acquire these highly-trained, deeply specialized individuals.
Christina Farr

About the author

Christina Farr

Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.

New York City

Share this article

Spread the word